Atrium Health Neuroscience Institute

Charlotte, North Carolina 28207

0 studies enrolling now · 2 studies all time

What they study most

ALS, Amyotrophic Lateral Sclerosis

Studies at this site

• A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031) — Stopped early
• An Efficacy and Safety Study of Ravulizumab in ALS Participants — Stopped early